Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Sensus Healthcare (SRTS) Shares Outstanding (2016 - 2026)

Sensus Healthcare has reported Shares Outstanding over the past 11 years, most recently at $17.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.12% year-over-year to $17.1 million; the TTM value through Dec 2025 reached $17.1 million, changed 0.12%, while the annual FY2025 figure was $17.1 million, 0.12% changed from the prior year.
  • Shares Outstanding for Q4 2025 was $16.5 million at Sensus Healthcare, roughly flat from $16.4 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $16.9 million in Q2 2024 and troughed at -$591809.0 in Q1 2025.
  • A 5-year average of $7.3 million and a median of -$75864.5 in 2021 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: surged 29977.91% in 2021 and later plummeted 103.5% in 2025.
  • Year by year, Shares Outstanding stood at -$77037.0 in 2021, then soared by 22041.09% to $16.9 million in 2022, then increased by 0.03% to $16.9 million in 2023, then rose by 0.77% to $17.0 million in 2024, then increased by 0.12% to $17.1 million in 2025.
  • Business Quant data shows Shares Outstanding for SRTS at $17.1 million in Q4 2025, -$591809.0 in Q3 2025, and $17.0 million in Q2 2025.